Nome Químico: 3-(1-oxo-4-(((3S,4R,5R)-3,5,6-trihydroxy-2-oxo-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexyl)amino)isoindolin-2-yl)piperidine-2,6-dione
Sorrisos: O[C@H](CO)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)C(CNC2=C(CN(C3C(NC(CC3)=O)=O)C4=O)C4=CC=C2)=O
Determination of possible potential genotoxic impurities in lenalidomide drug substance by simple RP-HPLC method
By Gaddam, Kishore; Kanne, Shanker; Gundala, Trivikram Reddy; Mamilla, Yogeshwar Reddy; Chinna, Gangi Reddy Nallagondu
From Asian Journal of Chemistry (2020), 32(12), 2965-2970
Development and validation of stability-indicating RP-HPLC method for the estimation of lenalidomide and its impurities in oral solid dosage form
By Prasad, Somana Siva; Mohan, G. V. Krishna; Babu, A. Naga
From Oriental Journal of Chemistry (2019), 35(1), 140-149
Simultaneous quantification of lenalidomide, ibrutinib and its active metabolite PCI-45227 in rat plasma by LC-MS/MS: Application to a pharmacokinetic study
By Veeraraghavan, Sridhar; Viswanadha, Srikant; Thappali, Satheeshmanikandan; Govindarajulu, Babu; Vakkalanka, Swaroopkumar; Rangasamy, Manivannan
From Journal of Pharmaceutical and Biomedical Analysis (2015), 107, 151-158